Article info
Colorectal
Original research
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study
- Correspondence to Dr Sailish Honap, IBD Centre, 1st Floor College House, Westminster Bridge Road, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK; shonap{at}nhs.net
Citation
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study
Publication history
- Received March 14, 2022
- Accepted April 18, 2022
- First published April 28, 2022.
Online issue publication
October 07, 2022
Article Versions
- Previous version (28 April 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.